loading
Virpax Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.242
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-13.24M
P/E Ratio:
0.00
EPS:
-8.83
Net Cash Flow:
$-16.85M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-97.91%
1Y Performance:
-99.74%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$0.00
52-Week Range:
Value
$0.00
$0.2869

Virpax Pharmaceuticals Inc Stock (VRPX) Company Profile

Name
Name
Virpax Pharmaceuticals Inc
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
VRPX's Discussions on Twitter

Compare VRPX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VRPX
Virpax Pharmaceuticals Inc
0.00 0 0 -13.24M -16.85M -8.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Virpax Pharmaceuticals Inc Stock (VRPX) Latest News

pulisher
Jul 18, 2025

Promising Nanotechnology Stocks To Watch Now – July 16th - Defense World

Jul 18, 2025
pulisher
Jul 16, 2025

Promising Nanotechnology Stocks To Watch NowJuly 16th - MarketBeat

Jul 16, 2025
pulisher
Jul 11, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading Down 2.9% – Should You Sell? - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

Promising Nanotechnology Stocks To Add to Your Watchlist – July 9th - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

Promising Nanotechnology Stocks To Add to Your WatchlistJuly 9th - MarketBeat

Jul 09, 2025
pulisher
Jul 09, 2025

Nanotechnology Stocks To Watch Today – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 05, 2025

Nanotechnology Stocks To Research – July 3rd - Defense World

Jul 05, 2025
pulisher
Jun 18, 2025

Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Nanotechnology Stocks To Watch NowJune 14th - MarketBeat

Jun 17, 2025
pulisher
Jun 11, 2025

Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat

Jun 11, 2025
pulisher
Jun 11, 2025

Nanotechnology Stocks To ResearchJune 8th - MarketBeat

Jun 11, 2025
pulisher
Jun 09, 2025

Nanotechnology Stocks To Follow NowJune 9th - MarketBeat

Jun 09, 2025
pulisher
Jun 02, 2025

Best Nanotechnology Stocks To Follow Today – May 31st - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading 4.4% Higher – Still a Buy? - Defense World

May 28, 2025
pulisher
May 15, 2025

Virpax Pharmaceuticals appoints new independent director - MSN

May 15, 2025
pulisher
May 13, 2025

Virpax and Nanomerics Enter Technology License Agreement for Developing A Product for PTSD Treatment - StatNano

May 13, 2025
pulisher
May 09, 2025

Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter

May 09, 2025
pulisher
May 06, 2025

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading Up 5.5% – Here’s What Happened - Defense World

May 06, 2025
pulisher
May 02, 2025

Virpax(R) Pharmaceuticals Announces Appointment of Michèle C. Linde, EVP, General Counsel - ACCESS Newswire

May 02, 2025
pulisher
Apr 15, 2025

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Sees Large Increase in Short Interest - Defense World

Apr 15, 2025
pulisher
Apr 09, 2025

Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference - MSN

Apr 09, 2025
pulisher
Apr 04, 2025

VRPX stock plunges to 52-week low, touches $1.07 - Investing.com Australia

Apr 04, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals to be delisted from Nasdaq By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Virpax Pharmaceuticals to be delisted from Nasdaq - Investing.com

Apr 03, 2025
pulisher
Mar 22, 2025

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split By Investing.com - Investing.com Australia

Mar 22, 2025
pulisher
Mar 21, 2025

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split - Investing.com India

Mar 21, 2025
pulisher
Mar 20, 2025

VRPX stock plunges to 52-week low of $0.12 amid market challenges - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals - Business Wire

Mar 20, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

VRPX stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Pharmaceuticals Announces Reverse Stock Split - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

Virpax Reports Positive Results From Dose Range Finding Study of Pain Relief Treatment in Beagle Dogs - MarketScreener

Mar 19, 2025
pulisher
Mar 18, 2025

Virpax receives positive Probudur(TM) results for dose range study -March 18, 2025 at 05:34 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Virpax reports positive results in Probudur dog study By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Virpax reports positive results in Probudur dog study - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough: Virpax's 5-Day Pain Drug Passes Critical Safety Test - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Virpax Pharmaceuticals Explores Intranasal mRNA Vaccine Delivery Using MET - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Virpax Pharmaceuticals stock hits 52-week low at $0.18 By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

Virpax Pharmaceuticals stock hits 52-week low at $0.18 - Investing.com

Mar 11, 2025

Virpax Pharmaceuticals Inc Stock (VRPX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):